Published in Lasers Surg Med on September 01, 2011
GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy. Cell Death Dis (2013) 0.95
Emerging targets in lipid-based therapy. Biochem Pharmacol (2012) 0.81
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Validating survivin as a cancer therapeutic target. Nat Rev Cancer (2003) 5.73
Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem (2003) 3.89
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res (2006) 3.17
An update on photodynamic therapy applications. J Clin Laser Med Surg (2002) 2.94
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res (2007) 2.82
Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta (2007) 2.31
The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res (1998) 2.00
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res (2006) 1.60
Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage. Photochem Photobiol (2007) 1.60
Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol Cancer Res (2008) 1.58
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene (2007) 1.57
Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo. Haematologica (2005) 1.55
Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer (2003) 1.52
Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal (2005) 1.33
Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res (1991) 1.30
Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B (2000) 1.27
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer (2001) 1.26
Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res (2007) 1.18
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res (2004) 1.15
Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res (2005) 1.12
Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response. J Cell Mol Med (2009) 1.08
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer (2006) 1.07
Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog (2006) 1.01
Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg Med (2006) 1.01
Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer (2003) 0.99
The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res (2004) 0.98
Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. J Environ Pathol Toxicol Oncol (2006) 0.96
Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis. Arch Otolaryngol Head Neck Surg (2008) 0.91
Fold up or perish: unfolded protein response and chemotherapy. Cell Death Differ (2007) 0.81
Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res (2007) 1.18
Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res (2002) 1.14
Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res (2005) 1.12
Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Hum Gene Ther (2004) 1.07
Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg Med (2006) 1.01
Just, in time: ethical implications of serial predictions of death and morbidity for ventilated premature infants. Pediatrics (2008) 0.99
The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res (2004) 0.98
Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. J Environ Pathol Toxicol Oncol (2006) 0.96
Targeting the 90 kDa heat shock protein improves photodynamic therapy. Cancer Lett (2009) 0.82
Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib. Cancer Lett (2011) 0.80
CHOP activation by photodynamic therapy increases treatment induced photosensitization. Lasers Surg Med (2004) 0.79
Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway. Photochem Photobiol (2008) 0.78
Multiple components of photodynamic therapy can phosphorylate Akt. Photochem Photobiol (2007) 0.77
Enhanced photodynamic therapy efficacy with inducible suicide gene therapy controlled by the grp promoter. Cancer Res (2002) 0.76
Targeting the tumor microenvironment using photodynamic therapy combined with inhibitors of cyclooxygenase-2 or vascular endothelial growth factor. Methods Mol Biol (2010) 0.76
Case 1: Axillary mass in a First Nations infant. Paediatr Child Health (2012) 0.75
Identification of MAP kinase pathways involved in COX-2 expression following photofrin photodynamic therapy. Methods Mol Biol (2010) 0.75